PL337234A1 - Derivatives of 5-naphtalen-1-yl-1,3-dioxane, their production and therapeutic application - Google Patents
Derivatives of 5-naphtalen-1-yl-1,3-dioxane, their production and therapeutic applicationInfo
- Publication number
- PL337234A1 PL337234A1 PL98337234A PL33723498A PL337234A1 PL 337234 A1 PL337234 A1 PL 337234A1 PL 98337234 A PL98337234 A PL 98337234A PL 33723498 A PL33723498 A PL 33723498A PL 337234 A1 PL337234 A1 PL 337234A1
- Authority
- PL
- Poland
- Prior art keywords
- naphtalen
- dioxane
- derivatives
- production
- therapeutic application
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9706946A FR2764289B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
| FR9706947A FR2764291B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
| FR9706945A FR2764288B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
| FR9706944A FR2764287B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique |
| PCT/FR1998/001113 WO1998055474A1 (fr) | 1997-06-05 | 1998-06-03 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL337234A1 true PL337234A1 (en) | 2000-08-14 |
Family
ID=27447000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL98337234A PL337234A1 (en) | 1997-06-05 | 1998-06-03 | Derivatives of 5-naphtalen-1-yl-1,3-dioxane, their production and therapeutic application |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0986552A1 (et) |
| JP (1) | JP2002502412A (et) |
| KR (1) | KR20010013435A (et) |
| CN (1) | CN1265658A (et) |
| AR (1) | AR012908A1 (et) |
| AU (1) | AU8025198A (et) |
| BG (1) | BG103937A (et) |
| BR (1) | BR9810742A (et) |
| CA (1) | CA2290695A1 (et) |
| CO (1) | CO4940480A1 (et) |
| EE (1) | EE9900560A (et) |
| HU (1) | HUP0002166A3 (et) |
| IL (1) | IL133242A0 (et) |
| NO (1) | NO995966L (et) |
| PL (1) | PL337234A1 (et) |
| SK (1) | SK166199A3 (et) |
| TR (1) | TR199903022T2 (et) |
| WO (1) | WO1998055474A1 (et) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7349301A (en) * | 2000-07-21 | 2002-02-05 | Ortho Mcneil Pharm Inc | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| FR2843964B1 (fr) | 2002-08-29 | 2004-10-01 | Sanofi Synthelabo | Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE111460T1 (de) * | 1990-06-15 | 1994-09-15 | Synthelabo | 2-(aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre herstellung und ihre anwendung in der therapeutik. |
| FR2714055B1 (fr) * | 1993-12-22 | 1996-01-19 | Synthelabo | Dérivés de 5-(arylalkyl)-1,3-dioxane substitués en position 2, leur préparation et leur utilisation en thérapeutique. |
| FR2742152B1 (fr) * | 1995-12-06 | 1998-01-16 | Synthelabo | Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique |
-
1998
- 1998-06-03 BR BR9810742-9A patent/BR9810742A/pt not_active IP Right Cessation
- 1998-06-03 KR KR1019997011436A patent/KR20010013435A/ko not_active Withdrawn
- 1998-06-03 EP EP98928419A patent/EP0986552A1/fr not_active Withdrawn
- 1998-06-03 WO PCT/FR1998/001113 patent/WO1998055474A1/fr not_active Ceased
- 1998-06-03 CN CN98807817A patent/CN1265658A/zh active Pending
- 1998-06-03 JP JP50172399A patent/JP2002502412A/ja active Pending
- 1998-06-03 AU AU80251/98A patent/AU8025198A/en not_active Abandoned
- 1998-06-03 PL PL98337234A patent/PL337234A1/xx unknown
- 1998-06-03 IL IL13324298A patent/IL133242A0/xx unknown
- 1998-06-03 SK SK1661-99A patent/SK166199A3/sk unknown
- 1998-06-03 TR TR1999/03022T patent/TR199903022T2/xx unknown
- 1998-06-03 CA CA002290695A patent/CA2290695A1/en not_active Abandoned
- 1998-06-03 AR ARP980102585A patent/AR012908A1/es unknown
- 1998-06-03 HU HU0002166A patent/HUP0002166A3/hu unknown
- 1998-06-03 EE EEP199900560A patent/EE9900560A/et unknown
- 1998-06-04 CO CO98031750A patent/CO4940480A1/es unknown
-
1999
- 1999-11-30 BG BG103937A patent/BG103937A/xx unknown
- 1999-12-03 NO NO995966A patent/NO995966L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO995966L (no) | 2000-02-04 |
| AU8025198A (en) | 1998-12-21 |
| EP0986552A1 (fr) | 2000-03-22 |
| EE9900560A (et) | 2000-06-15 |
| BR9810742A (pt) | 2000-09-12 |
| HUP0002166A2 (hu) | 2001-06-28 |
| BG103937A (en) | 2000-07-31 |
| WO1998055474A1 (fr) | 1998-12-10 |
| JP2002502412A (ja) | 2002-01-22 |
| SK166199A3 (en) | 2000-06-12 |
| HUP0002166A3 (en) | 2002-12-28 |
| CA2290695A1 (en) | 1998-12-10 |
| IL133242A0 (en) | 2001-03-19 |
| TR199903022T2 (xx) | 2000-04-21 |
| AR012908A1 (es) | 2000-11-22 |
| CN1265658A (zh) | 2000-09-06 |
| NO995966D0 (no) | 1999-12-03 |
| CO4940480A1 (es) | 2000-07-24 |
| KR20010013435A (ko) | 2001-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL325691A1 (en) | Derivatives of dithiolane, method of obtaining them and their therapeutic effects | |
| HU9802224D0 (en) | Pyrazol derivatives, process for producing them and their use as medicament | |
| PL329411A1 (en) | Novel derivatives of benzazepin, therapeutic agents containing such derivatives and their application in production of therapeutic agents | |
| LT2000004A (en) | Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments | |
| PL321003A1 (en) | Derivatives of piperasine, drugs containing them, their application and methods of obtaining them | |
| PL330841A1 (en) | Benzosulphonic derivatives, method of obtaining them and therapeutic agents containing such derivatives | |
| GB2327675B (en) | Nicotinamide derivatives and their use as medicaments | |
| PL323726A1 (en) | Novel derivatives of dolastatin, their production and application | |
| PL328608A1 (en) | Novel derivatives of erythromycin, method of obtaining them and their therapeutic application as drugs | |
| HU9800112D0 (en) | Biphenyl-sulfonyl-substituted heterocyclic compounds of fife-membered ring, their production and use | |
| PL341619A1 (en) | Derivatives of cyclobutane, method of obtaining them and their therapeutic application | |
| PL327854A1 (en) | Novel derivatives of benzoguanidin, method of obtaining them and their application in production of therapeutic agents | |
| PL323177A1 (en) | Azacycloalcane derivatives, method of obtaining them and their application for therapeutic purposes | |
| ZA9711168B (en) | New therapeutic application of pyrrole derivatives. | |
| PL329213A1 (en) | Novel derivatives of diarylmethylidene furane, method of obtaining them and their therapeutic application | |
| PL330257A1 (en) | Novel heterocyclic derivatives of benzocycloalkene, method of obtaining them and therapeutic agent | |
| PL320536A1 (en) | Derivatives of 3-benzoylopyridine, their production and application as herbicides | |
| PL330550A1 (en) | Novel aromatic ribose-substituted derivatives, method of obtaining them and their application as therapeutic agents | |
| PL332648A1 (en) | Derivatives of n-(2-benzothiazolyl)-1-piperidinethane mine, their production and application in medical therapy | |
| IL133558A0 (en) | Production of avermectin compounds | |
| HU9800472D0 (en) | New benzoxazinedion derivatives, process for producing them and use of them | |
| PL327059A1 (en) | Derivatives of 5-naphtalen-1-yl 1,3-dioxane, their production and therapeutic application | |
| PL337234A1 (en) | Derivatives of 5-naphtalen-1-yl-1,3-dioxane, their production and therapeutic application | |
| PL335675A1 (en) | Anticonvulsive derivatives of isoquinolinbenzamide | |
| HUP0003647A3 (en) | Bisethers of 1-oxa, aza and thianaphthalen-2-ones, their use for producing medicaments, the medicaments and their intermediates |